A phase 1, randomized, open-label, active-controlled trial to assess the safety of a meningococcal serogroup B bivalent rLP2086 vaccine in healthy adults. (Q38467225)
Jump to navigation
Jump to search
scientific article published on July 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 1, randomized, open-label, active-controlled trial to assess the safety of a meningococcal serogroup B bivalent rLP2086 vaccine in healthy adults. |
scientific article published on July 2012 |
Statements
A phase 1, randomized, open-label, active-controlled trial to assess the safety of a meningococcal serogroup B bivalent rLP2086 vaccine in healthy adults (English)
Howard Schwartz
Qin Jiang
Peter C Giardina